Noven Pharmaceuticals Sues Watson Laboratories

October 18, 2011

Noven Pharmaceuticals filed suit against Watson Laboratories over two patents related to treatments for attention deficit disorder.  10/13, District of New Jersey, 2:2011cv05997.

Access to the full article is currently available to RPX members only. Please contact us if you need further information.

Related News